EGFR and partial androgen insensitivity syndrome: Nowadays, fluorescent in-situ hybridization examination shows frequent amplification of PDGFRA (81%), MDM2 (65%), and EGFR (76%), which can be used to improve diagnostic identification of PAIS.[28]